Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia

Circulation Journal

Volumn 67, Issue 1, 2003, Pages 93-95

  Araki, Tsutomu ^a   Konno, Tetsuo ^a   Itoh, Hideki ^b   Ino, Hidekazu ^b   Shimizu, Masami ^b  

^a KANAZAWA CARDIOVASCULAR HOSPITAL   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

Author keywords

Brugada syndrome; Hypokalemia; Ventricular fibrillation; Ventricular tachycardia

Indexed keywords

ANTIALLERGIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; POTASSIUM; STEROID; THEOPHYLLINE;

ADULT; ARTICLE; ASTHMA; BRUGADA SYNDROME; CASE REPORT; DEFIBRILLATOR; DISEASE COURSE; ELECTROCARDIOGRAPHY MONITORING; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOKALEMIA; MALE; POTASSIUM BLOOD LEVEL; QT INTERVAL; RECURRENT DISEASE; SINUS RHYTHM; ST SEGMENT ELEVATION; SUDDEN DEATH; SYNCOPE; UNCONSCIOUSNESS;

BUNDLE-BRANCH BLOCK; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; HUMANS; HYPOKALEMIA; MALE; MIDDLE AGED; POTASSIUM; TACHYCARDIA, VENTRICULAR; VENTRICULAR FIBRILLATION;

EID: 0037241402     PISSN: 13469843     EISSN: None     Source Type: Journal    
DOI: 10.1253/circj.67.93     Document Type: Article

References (15)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396.
2. Alings M, Wilde A. 'Brugada' syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999; 99: 666-673.
3. Naccarelli GV, Antzelevitch C. The Brugada syndrome: Clinical, genetic, cellular, and molecular abnormalities. Am J Med 2001; 110: 573-581.
4. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: A marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998; 97: 457-460.
5. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Bringnole M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000; 102: 2509-2515.
6. Atarashi H, Ogawa S, Harumi K, Hayakawa H, Sugimoto T, Okada R, et al. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads: Idiopathic Ventricular Fibrillation Investigators. Am J Cardiol 1996; 78: 581-583.
7. Matsuo K, Shimizu W, Kurita T, Inagaki M, Aihara N, Kamakura S. Dynamic changes of 12-lead electrocardiograms in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 1998; 9: 508-512.
8. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation 1999; 100: 1660-1666.
9. Miyazaki T, Mitamura H, Miyoshi S, Soejima K, Aizawa Y, Ogawa S. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27: 1061-1070.
10. Kasanuki H, Ohnishi S, Ohtuka M, Matsuda N, Nirei T, Isogai R, et al. Idiopathic ventricular fibrillation induced with vagal activity in patients without obvious heart disease. Circulation 1997; 95: 2277-2285.
11. Matsuo K, Kurita T, Inagaki M, Kakishita M, Aihara N, Shimizu W, et al. The circadian pattern of the development of ventricular fibrillation in patients with Brugada syndrome. Eur Heart J 1999; 20: 465-470.
12. Itoh H, Shimizu M, Ino H, Okeie K, Yamaguchi M, Fujino N, et al. Arrhythmias in patients with Brugada-type electrocardiographic findings. Jpn Circ J 2001; 65: 483-486.
13. Helfant RH. Hypokalemia and arrhythmias. Am J Med 1986; 80: 13-22.
14. Brugada R, Brugada J, Antzelevitch C, Kirsch GE, Potenza D, Towbin JA, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101: 510-515.
15. Shimizu W, Antzelevitch C, Suyama K, Kurita T, Taguchi A, Aihara N, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11: 1320-1329.